Trevor Jarman

Prospero Biotech Ltd. (Prospero) is an independent UK private equity firm which specializes in providing formation management to early-stage bioventures. Based in London, Prosepro seeks to work with academic institutions who wish to commercialize their technology base, biotech ventures that may want to access new markets or that want to spin-off or sell a technology that is no longer core to their interests or corporations aiming to develop high potential new ventures in the medical or biotech sectors.

Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom.

Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom.

Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom.